WHO to restart Covid drug trial with focus on immune responses

World Health Organization (WHO) is set to restart an international clinical trial of three existing drugs that can save the lives of people hospitalised with Covid-19. This time the trial is aimed dampening inflammation, an approach that has already shown promise, Nature reported.

from US News Headlines, Latest USA News, US news live on Times of India https://ift.tt/3uDrX3N